Incyte (INCY) EPS (Weighted Average and Diluted) (2016 - 2025)
Incyte's EPS (Weighted Average and Diluted) history spans 16 years, with the latest figure at $1.46 for Q4 2025.
- For Q4 2025, EPS (Weighted Average and Diluted) rose 53.68% year-over-year to $1.46; the TTM value through Dec 2025 reached $6.41, up 3105.0%, while the annual FY2025 figure was $6.41, 4173.33% up from the prior year.
- EPS (Weighted Average and Diluted) reached $1.46 in Q4 2025 per INCY's latest filing, down from $2.11 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $2.54 in Q4 2021 to a low of -$2.04 in Q2 2024.
- Average EPS (Weighted Average and Diluted) over 5 years is $0.75, with a median of $0.76 recorded in 2023.
- Peak YoY movement for EPS (Weighted Average and Diluted): surged 1271.43% in 2021, then crashed 326.67% in 2024.
- A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $2.54 in 2021, then tumbled by 95.28% to $0.12 in 2022, then skyrocketed by 641.67% to $0.89 in 2023, then rose by 6.74% to $0.95 in 2024, then skyrocketed by 53.68% to $1.46 in 2025.
- Per Business Quant, the three most recent readings for INCY's EPS (Weighted Average and Diluted) are $1.46 (Q4 2025), $2.11 (Q3 2025), and $2.04 (Q2 2025).